However, in vitro modeling of porcupine inhibition in ligand-dependent CRC cell lines has identified selection for resistance mutations, such as loss-of-function alterations to AXIN1, leading to loss of function of the destruction complex and downstream constitutive pathway activation [46]. This evidence concerns the gene AXIN1 and colorectal carcinoma.